Literature DB >> 3792469

The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant.

Y Suzuki, T Curstedt, G Grossmann, T Kobayashi, R Nilsson, K Nohara, B Robertson.   

Abstract

An artificial surfactant was prepared by combining synthetic dipalmitoylphosphatidylcholine, dipalmitoylphosphatidylglycerol and the low-molecular weight (less than or equal to 15,000 daltons) surfactant apoproteins in the proportions 80:20:5. In the Wilhelmy balance, this surfactant formed a film with an equilibrium surface tension of 29 mN/m; surface tension was reduced to nearly zero during cyclic film compression, with effective respreadability during multiple compression-expansion cycles; similar surface properties were recorded with a pulsating bubble. When instilled into the airways of artificially ventilated immature newborn rabbits, the apoprotein-based artificial surfactant produced a five-fold increase in tidal volumes at insufflation pressure 25 cm H2O; this effect is similar to that obtained in previous experiments with natural surfactant phospholipids, administered in equal concentration (5 mg/ml). Higher concentration of the apoprotein-based surfactant could not be evaluated in vivo due to the high viscosity of the material. Systematic studies should be undertaken to find out whether an even more effective artificial surfactant could be prepared from the low-molecular weight apoproteins and other combinations of synthetic phospholipids.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792469

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  15 in total

1.  Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant.

Authors:  B Robertson; T Curstedt; G Grossmann; T Kobayashi; M Kokubo; Y Suzuki
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

2.  Identification of a cell membrane protein that binds alveolar surfactant.

Authors:  D S Strayer
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

Review 3.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

Review 4.  Pulmonary surfactant and its apoproteins.

Authors:  S Hawgood; J A Clements
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 5.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

6.  Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.

Authors:  S D Revak; T A Merritt; E Degryse; L Stefani; M Courtney; M Hallman; C G Cochrane
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

7.  Combinations of fluorescently labeled pulmonary surfactant proteins SP-B and SP-C in phospholipid films.

Authors:  K Nag; S G Taneva; J Perez-Gil; A Cruz; K M Keough
Journal:  Biophys J       Date:  1997-06       Impact factor: 4.033

8.  Antigenicity of low molecular weight surfactant species.

Authors:  D S Strayer; T A Merritt; C Makunike; M Hallman
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

9.  Purification, characterization and cDNA cloning of human lung surfactant protein D.

Authors:  J Lu; A C Willis; K B Reid
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

10.  The pulmonary surfactant protein C (SP-C) precursor is a type II transmembrane protein.

Authors:  A Keller; H R Eistetter; T Voss; K P Schäfer
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.